News
NVCR
--
0.00%
--
Top analysts recommend stocks like Alibaba and AutoZone amid the September sell-off
TipRanks analyst ranking service pinpointed some of the picks of Wall Street's best-performing analysts.
CNBC.com · 6h ago
The Best And Worst Large-Cap Stocks To Buy
Our overbought signal is improving, making it time to buy large-cap stocks.Here are the strongest and weakest large-cap sectors and industries to focus your attention on.The best and worst large-cap stocks include Black Knight, FactSet, and Alexion Pharmaceuticals.
Seekingalpha · 1d ago
Novocure Honors Mesothelioma Day with Activities to Raise Awareness of Mesothelioma and Support the Community
Novocure announced today initiatives to bring attention to Mesothelioma Awareness Day on September 26.
Business Wire · 1d ago
Here's What We Think About NovoCure's (NASDAQ:NVCR) CEO Pay
This article will reflect on the compensation paid to Asaf Danziger who has served as CEO of NovoCure Limited...
Simply Wall St. · 4d ago
The Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 17)
Benzinga · 09/18 11:30
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)
Benzinga · 09/17 11:59
Dow Jones Retraces A Third Of Its 1,735-Point Loss; Will These Growth Stocks Recover?
Investor's Business Daily · 09/09 19:12
Novocure to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
Novocure will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 9, 2020.
Business Wire · 09/04 12:30
NovoCure (NASDAQ:NVCR) Shareholders Have Enjoyed An Impressive 290% Share Price Gain
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...
Simply Wall St. · 08/24 20:29
Why I'm Worrying Over A Market Drop
Our overbought indicator reaches rarefied air.It could be a good time to rein in risk by reducing margin and avoiding short-term calls.The top stocks to add to buy if the market drops.
Seekingalpha · 08/17 20:22
Novocure Names CFO Wilco Groenhuysen COO; Names Ashley Cordova CFO
Benzinga · 08/13 12:37
NovoCure shares are trading higher after the company reported better-than-expected Q2 sales results and EPS results up from last year.
Benzinga · 07/30 17:59
NovoCure EPS beats by $0.02, beats on revenue
NovoCure (NASDAQ:NVCR): Q2 GAAP EPS of $0.02 beats by $0.02. Revenue of $115.93M (+33.7% Y/Y) beats by $9.97M. There were 3,278 active patients at June 30,
seekingalpha · 07/30 15:03
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)
Benzinga · 07/30 12:09
NovoCure Q2 EPS $0.02 Up From $(0.01) YoY, Sales $115.92M Beat $106.03M Estimate
NovoCure (NASDAQ:NVCR) reported quarterly earnings of $0.02 per share. This is a 300 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $115.92
Benzinga · 07/30 10:14
Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update
Novocure reported financial results for the quarter ended June 30, 2020, and provided a company update.
Business Wire · 07/30 10:00
NovoCure Limited (NVCR) CEO Asaf Danziger on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha · 07/30 04:00
NovoCure Q2 2020 Earnings Preview
Seeking Alpha · 07/29 18:55
Notable earnings before Thursday's open
Seeking Alpha · 07/29 16:32
Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
Novocure announced today the recipients of the AACR-Novocure Grants for Tumor Treating Fields Research program.
Business Wire · 07/28 11:30
Webull provides a variety of real-time NVCR stock news. You can receive the latest news about Novocure through multiple platforms. This information may help you make smarter investment decisions.
About NVCR
NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM) and to advance programs testing of TTFields in multiple solid tumor indications through its clinical pipeline. In addition to its clinical and commercial progress in GBM, it is planning or conducting clinical trials evaluating the use of TTFields in brain metastases, non-small-cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and mesothelioma. TTFields are delivered through a portable, medical device. The complete delivery system, which is designed to allow patients to go about their daily activities while receiving continuous cancer treatment, includes a portable electric field generator, transducer arrays, rechargeable batteries and accessories.
More